-transparent.png){kind=logo}
We have followed up until age 2 years 25 infants who had received the hepatitis B vaccine to prevent being infected from their mothers who were HBsAg carriers. All had developed antibodies. At 2 years of age, 24% of infants had antiHBsAg titers lower than 10 mU/ml. The geometric mean of antiHBsAg titer in those infants who had received plasma derived vaccine was 660 mU/ml and in those having received recombinant vaccine was 903 mU/ml. HBsAg was negative in all the studied samples. In two infants positive antiHBc were detected.
Related Publications
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
January 1988,
Hepatology (Baltimore, Md.),
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
July 1991,
Microbiologica,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
January 2007,
American family physician,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
January 1987,
Postgraduate medical journal,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
April 2011,
Vaccine,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
July 1997,
Archives of disease in childhood. Fetal and neonatal edition,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
January 1976,
British medical journal,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
February 1987,
Archives of disease in childhood,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
January 2019,
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
J M Torres, and
M Bruguera, and
E Fos, and
A Mayor, and
F R Hierro
October 1992,
The Pediatric infectious disease journal,
